Spirostachys africana
Spirostachys africana · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Spirostachys africana is a notable plant species that has gained scientific interest due to its diverse pharmacological potential. Research involving both dichloromethane extracts and crude aqueous extracts of its leaves has revealed significant antibacterial and antioxidant activities. These studies have specifically explored its impact on pathogens such as Candida albicans and its relevance in managing conditions like cough. Furthermore, investigations into its genotoxic properties and its interaction with enzymes like CYP1A2 and CYP3A4 provide critical insights into its biological safety. Understanding these multifaceted chemical properties is essential for uncovering the therapeutic value of this botanical resource.
- Synonyms
- Excoecaria Synandra · Excoecaria Africana · 4 more
- Common names
- Not available
- Family
- Euphorbiaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Synonyms
Spirostachys africana is a botanical species that is recognized by several different scientific names within various taxonomic classifications. Throughout botanical history, it has been referred to by the synonyms Excoecaria africana and Excoecaria synandra. Additionally, researchers have historically identified this plant under the names Myrica holtzii and Sapium africanum. The nomenclature also includes the designation Spirostachys synandra, reflecting the complexities of plant identification. Understanding these various synonyms is essential for accurately tracking the species across different scientific literature.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Spirostachys africana belongs to the vast kingdom Plantae, representing a unique branch of the natural world. Within this expansive realm, the species is classified under the class Equisetopsida. It further falls into the order Malpighiales, showcasing its specific evolutionary lineage. The plant is a member of the diverse Euphorbiaceae family, which is known for its wide variety of botanical characteristics. Finally, it is identified by its distinct genus, Spirostachys, which defines its unique biological identity.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Euphorbiaceae |
| Genus | Spirostachys |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Spirostachys africana is a notable plant species found across several diverse regions of the African continent. Its distribution spans the East Tropical Africa region, where it can be identified in both Kenya and Tanzania. Moving toward the southern parts of the continent, the species also flourishes throughout South Tropical Africa. Specifically, it is established in the landscapes of Angola, Mozambique, and Zimbabwe. This widespread presence highlights the plant's ability to adapt to various ecological zones across Africa.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Spirostachys africana is a distinctive tree that grows as a self-supporting plant within its natural habitat. This species displays a versatile range of development, with heights varying from a mere 0.5 m in young specimens to a maximum of 15 m. While it can exist at much smaller scales, many mature individuals typically reach a minimum height of 7.75 m. This structural diversity allows the tree to establish a significant presence in the landscape. Consequently, its growth form remains a key characteristic for identifying this resilient species.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Spirostachys africana is a South African medicinal plant that demonstrates a diverse range of biological activities. Research into its potential for treating diarrhea has confirmed that the plant possesses significant antibacterial properties against various microorganisms. Furthermore, studies investigating its therapeutic potential have highlighted its antioxidant activity. However, scientific evaluations regarding its safety have also revealed that extracts from the plant can be genotoxic in micronucleus tests. These varying results suggest that while the species offers medicinal benefits, its active principles require further investigation to ensure safe application.
Compounds
Spirostachys africana is a medicinal plant utilized by the Venda people of South Africa for treating ailments such as cough and fever. Research into its chemical composition has revealed that the bark of this species is particularly rich in specific phenolic compounds. Specifically, the plant contains high levels of flavonoids, measured at 11.57 μg/g. Furthermore, the bark is also characterized by a significant presence of gallotannins, which were detected at 48.88 μg/g. These high concentrations of phenolic substances are believed to be responsible for the plant's potent antimicrobial activities.
Conditions
Spirostachys africana exhibits inhibitory activity against the metabolic enzymes CYP1A2 and CYP3A4, which presents a potential risk for herb-drug interactions. The organic extracts of this plant's leaves demonstrate noteworthy antimicrobial efficacy against the pathogen Candida albicans. Furthermore, research indicates that Spirostachys africana possesses genotoxic properties. Finally, the plant has been investigated for its antimalarial potential through its activity against Plasmodium falciparum.
Preparations
Spirostachys africana is prepared as dichloromethane extracts to investigate their potential mutagenic and antimutagenic effects. These specific dichloromethane extracts were evaluated using both Salmonella/microsome and micronucleus tests. Additionally, Spirostachys africana is prepared as crude aqueous extracts for studies regarding herb-drug interactions. These aqueous extracts were specifically tested for their ability to inhibit major cytochrome P450 enzymes in human liver microsomes. The research demonstrates that both preparation methods are used to analyze the biological and pharmacological properties of the plant.
Parts used
Spirostachys africana leaf extracts have demonstrated significant potential in the treatment of oral infections. During antimicrobial testing, the organic extract from these leaves showed high efficacy against Candida albicans. Furthermore, the plant displayed remarkable anti-adherent properties, effectively reducing Streptococcus mutans biofilm formation by up to 97.56%. These findings highlight the plant's ability to combat adherent bacterial cells, which is critical in managing oral health. Ultimately, such results support the traditional use of this species in addressing various oral diseases.